NCT01140113

Brief Summary

The inflammatory response after cardiac surgery increases mortality and morbidity. Modified ultrafiltration (MUF) has been shown to decrease the post-cardiac surgery inflammatory response, to improve respiratory function, and cardiac performance in pediatric patients; however, this approach has not been well established in adults. The investigators therefore hypothesized that MUF can decrease the post-cardiac surgery inflammatory response and can improve cardiopulmonary function in adults.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable coronary-artery-disease

Timeline
Completed

Started Jul 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2007

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2008

Completed
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

June 7, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 9, 2010

Completed
Last Updated

July 23, 2013

Status Verified

July 1, 2013

Enrollment Period

1 year

First QC Date

June 7, 2010

Last Update Submit

July 21, 2013

Conditions

Keywords

hemoconcentrationultrafiltrationcoronary artery disease

Outcome Measures

Primary Outcomes (1)

  • Overall clinical improvement after cardiac surgeries.

    30 day after surgery

Secondary Outcomes (2)

  • The treatment group has less inflammatory markers

    30 days

  • The treatment group has improvements in the respiratory variables

    30

Study Arms (2)

Placebo

NO INTERVENTION

this group had undergone to routine coronary artery bypass graft surgery

Modified Ultrafiltration

EXPERIMENTAL

patients after weaning from bypass were submitted to ultrafiltration

Procedure: Modified Ultrafiltration

Interventions

After weaning from bypass patients had undergone to modified ultrafiltration for 15 minutes with a filtration flow at 300 ml/min

Also known as: Ultrafiltration
Modified Ultrafiltration

Eligibility Criteria

Age30 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elective patients to coronary artery bypass graft surgery
  • left ventricle ejection fraction higher than 40%

You may not qualify if:

  • renal impairment (serum creatinine higher than 1.7 mg%)
  • neoplasm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital da Clinicas

Campinas, São Paulo, 13100000, Brazil

Location

Related Publications (1)

  • Torina AG, Silveira-Filho LM, Vilarinho KA, Eghtesady P, Oliveira PP, Sposito AC, Petrucci O. Use of modified ultrafiltration in adults undergoing coronary artery bypass grafting is associated with inflammatory modulation and less postoperative blood loss: a randomized and controlled study. J Thorac Cardiovasc Surg. 2012 Sep;144(3):663-70. doi: 10.1016/j.jtcvs.2012.04.012. Epub 2012 May 9.

MeSH Terms

Conditions

Coronary Artery Disease

Interventions

Ultrafiltration

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular Diseases

Intervention Hierarchy (Ancestors)

Extracorporeal CirculationSurgical Procedures, OperativeFiltrationChemistry Techniques, AnalyticalInvestigative TechniquesPhysical PhenomenaChemical Phenomena

Study Officials

  • Orlando Petrucci, MD, PhD

    University of Campinas

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, PhD

Study Record Dates

First Submitted

June 7, 2010

First Posted

June 9, 2010

Study Start

July 1, 2007

Primary Completion

July 1, 2008

Study Completion

March 1, 2009

Last Updated

July 23, 2013

Record last verified: 2013-07

Locations